IgG4-associated diseases in the ENT area –⁠ a case report

Czech version

Authors: M. Vojtová ¹; Z. Balatková ^1,2; D. Kalfeřt ¹; J. Plzák ¹
Authors‘ workplace: Klinika otorinolaryngologie a chirurgie hlavy a krku 1. LF UK a FN v Motole, Praha ¹; Klinika ušní, nosní a krční 2. LF UK a FN v Motole, Praha ²
Published in: Otorinolaryngol Foniatr, 73, 2024, No. 4, pp. 270-273.
Category: Case Reports
doi: https://doi.org/10.48095/ccorl2024270

Overview

IgG4-related diseases (IgG4-RD) represent a group of rare systemic inflammatory conditions of unknown etiology and uncertain pathogenesis. Clinically, a wide range of symptoms can be observed in the ears, nose, and throat (ENT) area, depending on the tissue affected by the disease. Diagnosis is challenging relying on clinical presentation, histopathological evidence, radiological findings, and laboratory tests. Therapy typically involves long-term corticosteroid treatment often combined with immunosuppressive therapy. In our work, we present a case study of a patient with an extensive parapharyngeal space tumor, initially clinically and radiologically suggestive of malignancy, subsequently confirmed as an IgG4-related disease. The following article describes the clinical symptomatology of IgG4-RD in ENT and outlines the diagnostic approach to the presented case. Finally, the findings are summarized, emphasizing the necessity of multidisciplinary collaboration for proper differential diagnosis.

Keywords:

IgG4-related diseases – IgG4-RD – parapharyngeal space tumor

Sources

1. Hybášková J, Zeleník K, Urban O et al. Manifestace IgG4 asociované nemoci v oblasti hlavy a krku. Otorinolaryngolog Foniatr 2015; 64 (3): 163–167.

2. Závorková M, Richter J, Větvička V et al. IgG4 asociované onemocnění v očním lékařství Čes slov Oftal 2017; 73 (3): 109–112.

3. Liard Y, Nigolian H, Lobrinus JA et al. ENT and head and neck manifestations of the IgG4-related disease. Rev Med Suisse 2020; 16 (709): 1870–1875.

4. Umehara H, Okazaki K, Kawa S et al. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol 2021; 31 (3): 529–533. Doi: 10.1080/14397595.2020.1859710.

5. Maritati F, Peyronel F, Vaglio A. IgG4-related disease: a clinical perspective. Rheumatology (Oxford) 2020; 59 (Suppl 3): iii123–iii131. Doi: 10.1093/rheumatology/kez667.

6. Johnston J, Allen JE. IgG4-related disease in the head and neck. Curr Opin Otolaryngol Head Neck Surg 2018; 26 (6): 403–408. Doi: 10.1097/MOO.0000000000000487.

7. Yasuda MA, Sandelski M, Borrowdale R. IgG4-RD in a Unilateral Parotid Mass: A Rare Manifestation and Review of the Literature. Cureus 2023; 15 (3): e35689. Doi: 10.7759/cureus.35689.

8. Czarnywojtek A, Agaimy A, Pietronczyk K et al. IgG4-related disease: an update on pathology and diagnostic criteria with a focus on salivary gland manifestations. Virchows Arch 2024; 484 (3): 381–399. Doi: 10.1007/s00428-024-03757-0.

9. Navarro-Sanchez V, Marin-Castaneda LA, Gallegos CA et al. IgG4-Related Fibrous Thyroiditis (Riedel‘s Thyroiditis): A Case Report. Am J Case Rep 2020; 21: e928046. Doi: 10.12659/AJCR.928046.

10. Adam Z, Zeman D, Čermák A et al. Onemocnění asociované s imunoglobulinem IgG4. Klinické příznaky, diferenciální diagnostika a recentní mezinárodní diagnostická kritéria. Vnitr Lek. 2022; 68 (5): E20–E26. Doi: 10.36290/vnl.2022.070.

11. Ren Q, Su J, Zhang D et al. Otological IgG4-Related Disease With Inner Ear Involvement: A Case Report and Review of Literature. Ear Nose Throat J 2022; 101 (10): NP441–NP444. Doi: 10.1177/0145561320976411.

12. Lanzillotta M, Mancuso G, Della-Torre E. Advances in the diagnosis and management of IgG4 related disease. BMJ 2020; 369: m1067. Doi: 10.1136/bmj.m1067.

ORCID autorů

J. Plzák 0000-0003-3710-4455,

Z. Balatková 0000-0003-1121-9836,

D. Kalfeřt 0000-0003-4369-4113.

Přijato k recenzi: 26. 5. 2024

Přijato k tisku: 28. 7. 2024

MUDr. Michaela Vojtová

Klinika otorinolaryngologie a chirurgie hlavy a krku

1. LF UK a FN v Motole

V Úvalu 84

150 06 Praha 5

michaela.vojtova@fnmotol.cz